BMBF-Network TB-Sequel: Concomitant diseases, risk factors and long-term complications that define the individual therapeutic success of tuberculosis and its impact on public health.
- Coordinator: Dr. Gavin Churchyard, Südafrika
- German contact person: Prof. Dr. Michael Hoelscher
- Affiliation: Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich
- Participating countries: Tansania, Mozambique, Gambia, South Africa
- Funding by BMBF: 2016 to 2021
The African continent today is emblematic of tuberculosis (TB) as a global health emergency with little known about the long-term sequelae. There is cumulative evidence for prolonged pulmonary morbidity and loss of longevity in former TB patients. It is likely that TB patients from resource-constrained settings, who usually present with more extensive disease, are left with substantial and chronic lung impairment.
This project aims:
- to advance the understanding of the clinical, microbiologic, environmental and host immune factors affecting the long-term sequelae of pulmonary TB;
- to determine occurrence of reversible and irreversible costs and socioeconomic consequences for TB patients and health care systems;
- and to facilitate novel interventions to restore and preserve overall health, well-being and financial protection in patients with TB.
Source: TB Sequel